Results 31 to 40 of about 1,478,682 (342)
Apex-Map: A Global Data Access Benchmark to Analyze HPC Systems and Parallel Programming Paradigms [PDF]
ACM/IEEE SC 2005 Conference (SC'05), 2005 The memory wall and global data movement have become the dominant performance bottleneck for many scientific applications. New characterizations of data access streams and related benchmarks to measure their performances are therefore needed to compare HPC systems, software, and programming paradigms effectively.
Strohmaier, Erich, Shan, Hongzhang
openaire +2 more sources
BMJ Open, 2021 Objectives Patients with highly resistant tuberculosis have few treatment options. Bedaquiline, pretomanid and linezolid regimen (BPaL) is a new regimen shown to have favourable outcomes after six months.
Francesca Conradie +13 more
doaj +1 more source
Allergy, Asthma & Clinical Immunology, 2021 Background The Global Initiative for Asthma recommends the use of as-needed low-dose inhaled corticosteroid (ICS)-formoterol as a preferred controller therapy for patients with mild asthma.
Mohsen Sadatsafavi +6 more
doaj +1 more source
China Joins Global Health Governance: New Player, More Medicines, and New Rules? [PDF]
, 2014 In the wake of China’s rapid ascendancy, are there any new rules made by the country in global health governance? This paper examines China’s emerging role in the Agreement on Trade-Related Aspects of Intellectual Property Rights, and finds that China ...
Lee, Pak K. +3 more
core +1 more source
Establishing targets for advanced HIV disease: A call to action
Southern African Journal of HIV Medicine, 2021 The World Health Organization (WHO) has published a guideline for the management of individuals with advanced HIV disease (AHD) to reduce HIV-related deaths.
David B. Meya +20 more
doaj +1 more source
Journal of immunotherapy, 2017 KEYNOTE-030 (ClinicalTrials.gov ID, NCT02083484) was a global expanded access program that allowed access to pembrolizumab, an antiprogrammed death 1 antibody, for patients with advanced melanoma before its regulatory approval. Patients with unresectable
T. Gangadhar +16 more
semanticscholar +1 more source
Launching DataCite's Global Access Program in Asia: Improving Equity, Access, and PID Adoption
, 2023 Asian countries are producing various research outputs and resources, such as datasets, dissertations, and protocols. These outputs are not getting the recognition and visibility they deserve. Adoption of persistent identifiers (PIDs) can improve the discoverability of these outputs and promote reusability by sharing them with the broader research ...
openaire +2 more sources
The silent and dangerous inequity around access to COVID-19 testing: A call to action
EClinicalMedicine, 2021 M edecins Sans Fronti eres, Rio de Janeiro, Brazil Texas Children’s Center for Vaccine Development, Baylor College of Medicine, Houston, TX, USA Center for Sustainable Development, Columbia University, New York, New York, United States of America ...
C. Batista +21 more
semanticscholar +1 more source
Future Oncology, 2014 AIM Cabazitaxel is a novel taxane that is approved for use in metastatic castration-resistant prostate cancer based on the Phase III TROPIC study, which showed improved overall survival with cabazitaxel/prednisone versus mitoxantrone/prednisone. A global
S. Bracarda +20 more
semanticscholar +1 more source
Access to vaccines in Brazil and the global dynamics of the Health Economic-Industrial Complex.
Cadernos de Saúde Pública, 2020 This study analyzed the main economic trends, market structure, production, and innovation in vaccines against infectious diseases at the global and national levels, observing the effects on access to vaccination in Brazil and on the sustainability of ...
C. Gadelha +3 more
semanticscholar +1 more source